DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Slamon D, Eiermann W, Robert N. et al. Breast Cancer International Research Group.
Adjuvant trastuzumab in HER2-positive breast cancer.
N Engl J Med 2011;
365: 1273-1283
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.